Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Elects Partnership Class of 29 and Counsel Class of 15 Across Europe and U.S.December 11, 2025EU Digital Omnibus: Implications for MedTech CompaniesDecember 10, 2025EU Digital Omnibus: The European Commission Proposes Important Changes to the EU’s Digital RulebookDecember 9, 2025EU Digital Omnibus: The European Commission Proposes Important Changes to the EU's Digital RulebookDecember 9, 2025Sidley Advises Bessemer Investors on Strategic Investment in XanitosDecember 9, 2025Sidley Advises Ancala on Acquisition of U.S. Chemical Infrastructure PortfolioDecember 4, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory